Technical Analysis for STRO - Sutro Biopharma, Inc.

Grade Last Price % Change Price Change
grade B 10.78 -0.42% -0.05
STRO closed down 0.42 percent on Friday, November 15, 2019, on 29 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical STRO trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion -0.42%
Upper Bollinger Band Touch Strength -0.42%
Narrow Range Bar Range Contraction -0.19%
Narrow Range Bar Range Contraction 0.09%
Earnings Movers Other 0.09%
Earnings Movers Other -0.28%
Shooting Star Candlestick Bearish -1.82%
Doji - Bearish? Reversal -1.82%
Upper Bollinger Band Walk Strength -1.82%
Upper Bollinger Band Touch Strength -1.82%

Older signals for STRO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers. It has collaboration and license agreement with Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Medicine Cancer Clinical Medicine Immunology California Antibodies Drug Discovery Cancer Treatments Multiple Myeloma Antineoplastic Drugs Autoimmune Disorders Sutro Biopharma Non Hodgkin Lymphoma Adc Immunogen South San Francisco Therapeutics For Cancer Milatuzumab
Is STRO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.58
52 Week Low 7.69
Average Volume 52,230
200-Day Moving Average 10.3873
50-Day Moving Average 9.9661
20-Day Moving Average 10.4148
10-Day Moving Average 10.7115
Average True Range 0.6007
ADX 35.66
+DI 31.2886
-DI 11.5977
Chandelier Exit (Long, 3 ATRs ) 9.7979
Chandelier Exit (Short, 3 ATRs ) 10.9638
Upper Bollinger Band 11.2934
Lower Bollinger Band 9.5362
Percent B (%b) 0.71
BandWidth 16.872143
MACD Line 0.3132
MACD Signal Line 0.2853
MACD Histogram 0.028
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.60
Resistance 3 (R3) 11.60 11.34 11.46
Resistance 2 (R2) 11.34 11.13 11.33 11.42
Resistance 1 (R1) 11.06 11.00 10.93 11.05 11.37
Pivot Point 10.79 10.79 10.73 10.79 10.79
Support 1 (S1) 10.51 10.58 10.38 10.51 10.19
Support 2 (S2) 10.25 10.45 10.24 10.14
Support 3 (S3) 9.97 10.25 10.10
Support 4 (S4) 9.96